SE9200858D0 - Process for the preparation of sustained releade pellets - Google Patents

Process for the preparation of sustained releade pellets

Info

Publication number
SE9200858D0
SE9200858D0 SE9200858A SE9200858A SE9200858D0 SE 9200858 D0 SE9200858 D0 SE 9200858D0 SE 9200858 A SE9200858 A SE 9200858A SE 9200858 A SE9200858 A SE 9200858A SE 9200858 D0 SE9200858 D0 SE 9200858D0
Authority
SE
Sweden
Prior art keywords
pct
binder
sec
pellets
sustained
Prior art date
Application number
SE9200858A
Other languages
English (en)
Other versions
SE9200858L (sv
Inventor
H G Kristensen
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9200858A priority Critical patent/SE9200858L/sv
Publication of SE9200858D0 publication Critical patent/SE9200858D0/sv
Priority to AU39111/93A priority patent/AU675062B2/en
Priority to EP93908213A priority patent/EP0630235B1/en
Priority to DE69311800T priority patent/DE69311800T2/de
Priority to AT93908213T priority patent/ATE154756T1/de
Priority to ES93908213T priority patent/ES2105240T3/es
Priority to US08/307,629 priority patent/US5807583A/en
Priority to CA002132451A priority patent/CA2132451C/en
Priority to PCT/SE1993/000225 priority patent/WO1993018753A1/en
Priority to DK93908213.7T priority patent/DK0630235T3/da
Priority to JP5516457A priority patent/JPH07505360A/ja
Publication of SE9200858L publication Critical patent/SE9200858L/sv
Priority to GR970402248T priority patent/GR3024604T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
SE9200858A 1992-03-20 1992-03-20 Metod för framställning av pellets med fördröjd frisättning SE9200858L (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9200858A SE9200858L (sv) 1992-03-20 1992-03-20 Metod för framställning av pellets med fördröjd frisättning
JP5516457A JPH07505360A (ja) 1992-03-20 1993-03-16 持効性ペレット剤の調製方法
AT93908213T ATE154756T1 (de) 1992-03-20 1993-03-16 Verfahren zur herstellung von pellets mit verzögerter freisetzung
EP93908213A EP0630235B1 (en) 1992-03-20 1993-03-16 Process for the preparation of sustained release pellets
DE69311800T DE69311800T2 (de) 1992-03-20 1993-03-16 Verfahren zur herstellung von pellets mit verzögerter freisetzung
AU39111/93A AU675062B2 (en) 1992-03-20 1993-03-16 Process for the preparation of sustained release pellets
ES93908213T ES2105240T3 (es) 1992-03-20 1993-03-16 Procedimiento para la preparacion de pellets de liberacion retardada.
US08/307,629 US5807583A (en) 1992-03-20 1993-03-16 Process for the preparation of sustained release pellets
CA002132451A CA2132451C (en) 1992-03-20 1993-03-16 Process for the preparation of sustained release pellets
PCT/SE1993/000225 WO1993018753A1 (en) 1992-03-20 1993-03-16 Process for the preparation of sustained release pellets
DK93908213.7T DK0630235T3 (da) 1992-03-20 1993-03-16 Fremgangsmåde til fremstilling af pellets med forsinket frigivelse
GR970402248T GR3024604T3 (en) 1992-03-20 1997-09-02 Process for the preparation of sustained release pellets.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9200858A SE9200858L (sv) 1992-03-20 1992-03-20 Metod för framställning av pellets med fördröjd frisättning

Publications (2)

Publication Number Publication Date
SE9200858D0 true SE9200858D0 (sv) 1992-03-20
SE9200858L SE9200858L (sv) 1993-09-21

Family

ID=20385679

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9200858A SE9200858L (sv) 1992-03-20 1992-03-20 Metod för framställning av pellets med fördröjd frisättning

Country Status (12)

Country Link
US (1) US5807583A (sv)
EP (1) EP0630235B1 (sv)
JP (1) JPH07505360A (sv)
AT (1) ATE154756T1 (sv)
AU (1) AU675062B2 (sv)
CA (1) CA2132451C (sv)
DE (1) DE69311800T2 (sv)
DK (1) DK0630235T3 (sv)
ES (1) ES2105240T3 (sv)
GR (1) GR3024604T3 (sv)
SE (1) SE9200858L (sv)
WO (1) WO1993018753A1 (sv)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US5968551A (en) 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
GB2284760B (en) * 1993-11-23 1998-06-24 Euro Celtique Sa A method of preparing pharmaceutical compositions by melt pelletisation
IL119660A (en) * 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
US5690959A (en) * 1993-05-29 1997-11-25 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
IL109944A (en) * 1993-07-01 1998-12-06 Euro Celtique Sa Continuous release dosage form containing morphine and a method of preparing such sustained release unit dosage forms
DE69429710T2 (de) * 1993-11-23 2002-08-08 Euro Celtique Sa Verfahren zur Herstellung einer Arzneizusammensetzung mit verzögerter Wirkstoffabgabe
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US6524832B1 (en) * 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
EP0672416A1 (en) * 1994-03-14 1995-09-20 Euro-Celtique S.A. Pharmaceutical composition comprising diamorphine
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5827537A (en) * 1995-05-04 1998-10-27 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
GB9519363D0 (en) * 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
DE19705538C1 (de) * 1997-02-14 1998-08-27 Goedecke Ag Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen
DE19729487A1 (de) * 1997-07-10 1999-01-14 Dresden Arzneimittel Verfahren zur Herstellung von Wirkstoff-Zubereitungen mit kontrollierter Freisetzung aus einer Matrix
AU9496798A (en) * 1997-09-19 1999-04-05 Shire Laboratories, Inc. Solid solution beadlet
DK173431B1 (da) 1998-03-20 2000-10-23 Gea Farmaceutisk Fabrik As Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
KR101476574B1 (ko) 1999-10-29 2014-12-24 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
US6953593B2 (en) * 2000-02-01 2005-10-11 Lipoprotein Technologies, Inc. Sustained-release microencapsulated delivery system
EP1322158B1 (en) * 2000-10-02 2012-08-08 USV Ltd. Sustained release pharmaceutical compositions containing metformin and method of their production
ATE442852T1 (de) 2000-10-05 2009-10-15 Usv Ltd Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
MXPA03003895A (es) 2000-10-30 2003-07-28 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada.
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
DE10300325A1 (de) 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
KR100712356B1 (ko) * 2003-01-23 2007-05-02 (주)아모레퍼시픽 서방성 제제 및 그의 제조방법
US8034605B2 (en) * 2003-03-26 2011-10-11 Kyu-Jin Yum Microbial materials for degradation of oils and toxic chemicals
KR100412759B1 (en) * 2003-03-26 2004-01-07 Kyu Jin Yum Microbial preparation for decomposing oils and toxic chemicals
US20050025825A1 (en) * 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US20090214644A1 (en) * 2003-07-31 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations with reduced adverse effects
KR101140559B1 (ko) * 2003-08-20 2012-07-05 제노포트 인코포레이티드 아실옥시알킬 카르바메이트 프로드러그, 합성 및 사용 방법
EP1716115B1 (en) * 2003-12-30 2013-02-27 XenoPort, Inc. Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
US20090215898A1 (en) * 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US8022106B2 (en) * 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
US20050245614A1 (en) * 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
WO2005123042A1 (en) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc. Controlled release pharmaceutical formulation
US9034373B2 (en) * 2006-03-16 2015-05-19 Euro-Celtique S.A. Pharmaceutical spheroids
CA2677989C (en) 2007-02-20 2018-04-24 Eurand Pharmaceuticals Limited Stable digestive enzyme compositions
US10888521B2 (en) * 2007-03-02 2021-01-12 Farnam Companies, Inc. Sustained release compositions using wax-like materials
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
US20100280117A1 (en) * 2009-04-30 2010-11-04 Xanodyne Pharmaceuticals, Inc. Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
MX348118B (es) 2010-10-01 2017-05-26 Aptalis Pharma Ltd Formulaciones de pancrelipasa con recubrimiento enterico de baja potencia.
EP2987499B1 (en) 2011-08-08 2019-05-08 Allergan Pharmaceuticals International Limited Method for dissolution testing of solid compositions containing digestive enzymes
EP2790729A4 (en) * 2011-12-12 2015-08-12 Orbis Biosciences Inc PARTICULATE FORMULATIONS WITH DELAYED RELEASE
US10184121B2 (en) 2013-06-28 2019-01-22 Allergan Pharmaceuticals International Limited Methods for removing viral contaminants from pancreatic extracts
RU2679832C2 (ru) 2013-08-09 2019-02-13 Аллерган Фармасьютикалз Интернэйшнл Лимитед Композиция пищеварительных ферментов, подходящая для энтерального введения
US11813361B2 (en) 2014-04-04 2023-11-14 Pharmaquest International Center, Llp Disintegrating monolithic modified release tablets containing quadri-layer extended release granules
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
US5008112A (en) * 1985-12-16 1991-04-16 International Minerals & Chem. Corporation Device for the extended delivery of diffusible agents
DE3721721C1 (de) * 1987-07-01 1988-06-09 Hoechst Ag Verfahren zur Umhuellung von Granulaten
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法
DK161743C (da) * 1989-07-03 1992-02-17 Niro Atomizer As Fremgangsmaade og apparat til agglomerering af et pulverformigt materiale
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
US5358560A (en) * 1991-10-04 1994-10-25 Eastman Chemical Company Solid-form additive systems dispersible in aqueous media and method for their preparation

Also Published As

Publication number Publication date
EP0630235B1 (en) 1997-06-25
AU3911193A (en) 1993-10-21
ATE154756T1 (de) 1997-07-15
EP0630235A1 (en) 1994-12-28
DK0630235T3 (da) 1998-02-02
CA2132451C (en) 2003-06-10
CA2132451A1 (en) 1993-09-30
WO1993018753A1 (en) 1993-09-30
DE69311800T2 (de) 1998-01-08
US5807583A (en) 1998-09-15
DE69311800D1 (de) 1997-07-31
GR3024604T3 (en) 1997-12-31
ES2105240T3 (es) 1997-10-16
JPH07505360A (ja) 1995-06-15
SE9200858L (sv) 1993-09-21
AU675062B2 (en) 1997-01-23

Similar Documents

Publication Publication Date Title
SE9200858D0 (sv) Process for the preparation of sustained releade pellets
TW348062B (en) Sustained release compositions
DE69115711T2 (de) Verfahren zur arzneiformulierung sowie arzneimittel
GB2186485B (en) Slow release formulation
DE3883251T2 (de) Latex enthaltende agrochemische zusammensetzungen.
ATE35422T1 (de) Verfahren zur herstellung von pigmentzusammensetzungen.
DE3683385D1 (de) Einrichtungen fuer die kontrollierte abgabe von aktiven substanzen und verfahren zu ihrer herstellung.
BR9810168A (pt) Processo para produção de um produto detergente granular, e, produto detergente granular
WO1999031141A3 (de) Verfahren zur herstellung von regulären porösen perlcellulosen, die perlcellulosen und ihre verwendung
GEP19981475B (en) Solid Group Preparation for Shielding of ultivated Plants and Method for Its Production
MX9206420A (es) Procedimiento para aglomerar material en particulas y productos hechos a partir de dicho procedimiento.
BR9607678A (pt) Novos concentrados aditivos
DE69525620T2 (de) Verfahren für die herstellung schmelz-granulierte sucralfatzubereitung
DE2810141A1 (de) Verfahren zur herstellung von presskoerpern, insbesondere tabletten, mit labilen substanzen in mikrodispersion
KR900013846A (ko) 방출제어된 수전재초용 과립제
ATE56752T1 (de) Verfahren zur herstellung einer poroesen struktur, die eine in einem bindemittel ausgestreute organische substanz enthaelt.
KR890004995A (ko) 안정된 입상농약비료
Lee et al. The Dynamical Aperture of Booster
JPS56164111A (en) Isosorbitol nitrate preparation
JPS53130282A (en) Granulating method for powder
JPS5337586A (en) Granulating method for inorganic powdery substance
JPS5672660A (en) Granulated and refined konjak flour and its preparation

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9200858-0

Effective date: 19941001

Format of ref document f/p: F